BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Janjusevic M, Fluca AL, Ferro F, Gagno G, D'Alessandra Y, Beltrami AP, Sinagra G, Aleksova A. Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction-Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage. Int J Mol Sci 2021;22:4937. [PMID: 34066533 DOI: 10.3390/ijms22094937] [Reference Citation Analysis]
2 Hu X, Ning X, Zhao Q, Zhang Z, Zhang C, Xie M, Huang W, Cai Y, Xiang Q, Ou C. Islet-1 Mesenchymal Stem Cells-Derived Exosome-Incorporated Angiogenin-1 Hydrogel for Enhanced Acute Myocardial Infarction Therapy. ACS Appl Mater Interfaces 2022. [PMID: 35920579 DOI: 10.1021/acsami.2c04686] [Reference Citation Analysis]
3 Yuan Z, Huang W. New Developments in Exosomal lncRNAs in Cardiovascular Diseases. Front Cardiovasc Med 2021;8:709169. [PMID: 34307511 DOI: 10.3389/fcvm.2021.709169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Suades R, Greco MF, Padró T, Badimon L. Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis. Cells 2022;11:1845. [DOI: 10.3390/cells11111845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saludas L, Garbayo E, Ruiz-Villalba A, Hernández S, Vader P, Prósper F, Blanco-Prieto MJ. ISOLATION METHODS OF LARGE AND SMALL EXTRACELLULAR VESICLES DERIVED FROM CARDIOVASCULAR PROGENITORS: A COMPARATIVE STUDY. Eur J Pharm Biopharm 2021:S0939-6411(21)00361-1. [PMID: 34968647 DOI: 10.1016/j.ejpb.2021.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Manickam DS. Delivery of mitochondria via extracellular vesicles – A new horizon in drug delivery. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.01.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Boffito M, Ciardelli G. Biomaterials Tailoring at the Nanoscale for Tissue Engineering and Advanced Therapies. Nanomaterials (Basel) 2021;11:1221. [PMID: 34066333 DOI: 10.3390/nano11051221] [Reference Citation Analysis]
8 Gao Y, Wu D, Jia D, Guo Q, Wang M, Yang R, Zhang X, Chen M, Zhang D. Hypoxic Stem Cell-Derived Extracellular Vesicles for Cardiac Repair in Preclinical Animal Models of Myocardial Infarction: A Meta-Analysis. Stem Cells Dev 2021. [PMID: 34271845 DOI: 10.1089/scd.2021.0084] [Reference Citation Analysis]
9 Claridge B, Lozano J, Poh QH, Greening DW. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol 2021;9:734720. [PMID: 34616741 DOI: 10.3389/fcell.2021.734720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]